Detalles de la búsqueda
1.
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study.
Diabet Med;
38(9): e14405, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32961617
2.
Hyperoxia improves autonomic function in individuals with long-duration type 1 diabetes and macroalbuminuria.
Diabet Med;
37(9): 1561-1568, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32353914
3.
Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes.
Diabet Med;
35(11): 1596-1604, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29999549
4.
Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case-control study.
Diabet Med;
35(10): 1337-1344, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29797352
5.
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
Diabet Med;
35(10): 1375-1382, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29781558
6.
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
Cardiovasc Diabetol;
16(1): 55, 2017 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28446168
7.
Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes.
Diabetes Metab Res Rev;
33(5)2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28303635
8.
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus.
Diabet Med;
33(12): 1625-1631, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27504739
9.
Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
J Intern Med;
277(3): 362-371, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24830873
10.
Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
Diabet Med;
32(11): 1445-52, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26331364
11.
Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
Diabet Med;
32(3): 374-81, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25307511
12.
Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.
Diabet Med;
32(3): 343-52, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25251901
13.
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.
Diabet Med;
32(8): 1104-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819010
14.
Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Diabet Med;
31(9): 1138-47, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24661264
15.
Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study.
Diabetologia;
56(1): 22-30, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23011351
16.
Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes.
Diabetologia;
56(2): 323-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23111731
17.
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1.
Diabetologia;
56(8): 1845-55, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23620061
18.
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.
Diabetologia;
56(2): 259-67, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23086559
19.
The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial.
Diabet Med;
35(3): 392-393, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315768
20.
Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
Diabet Med;
30(5): 563-6, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23324103